ARTL · Company research

Artelo Biosciences, Inc. (ARTL): Stock News & Events

Recent company-linked news records available in the database.

RESEARCH CONTEXT

Understand the numbers

Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.

16records availableHealthcare

Stock News & Events data

Database-backed records only

16 rows
titlesummaryurlsourcepublished atsentimentsentiment scorerelevance score
About 180 companies were identified below a Nasdaq threshold, including Artelo Biosciences (Nasdaq: ARTL). - Stock TitanAbout 180 companies were identified below a Nasdaq threshold, including Artelo Biosciences (Nasdaq: ARTL). Stock TitanView source ↗Stock TitanOct 9, 2026neutral00.6
A drug eased arthritis pain comparably to naproxen in animals, with less stomach damage. - Stock TitanA drug eased arthritis pain comparably to naproxen in animals, with less stomach damage. Stock TitanView source ↗Stock TitanOct 7, 2026neutral00.6
Artelo Biosciences Files Provisional Obesity Patent | ARTL Stock News - Stock TitanArtelo Biosciences Files Provisional Obesity Patent | ARTL Stock News Stock TitanView source ↗Stock TitanSep 23, 2026neutral00.6
Artelo Biosciences Announces Reverse Stock Split - Yahoo FinanceArtelo Biosciences Announces Reverse Stock Split Yahoo FinanceView source ↗Yahoo FinanceAug 27, 2026neutral00.6
Artelo Biosciences will combine every 9 shares into 1 starting Aug. 31 - Stock TitanArtelo Biosciences will combine every 9 shares into 1 starting Aug. 31 Stock TitanView source ↗Stock TitanAug 27, 2026neutral00.6
Artelo Biosciences stock tumbles on $6.5M share offering - Investing.comArtelo Biosciences stock tumbles on $6.5M share offering Investing.comView source ↗Investing.comMay 27, 2026neutral00.6
ARTL Stock In Focus As Artelo Biosciences Taps AI For Drug Pipeline - StocksToTradeARTL Stock In Focus As Artelo Biosciences Taps AI For Drug Pipeline StocksToTradeView source ↗StocksToTradeMay 26, 2026neutral00.6
Artelo Biosciences jumps after Nasdaq compliance update, with low-float volatility likely adding fuel | ARTL Stock News - Quiver QuantitativeArtelo Biosciences jumps after Nasdaq compliance update, with low-float volatility likely adding fuel | ARTL Stock News Quiver QuantitativeView source ↗Quiver QuantitativeApr 20, 2026neutral00.6
ARTL Stock Draws Traders As Biotech Pipeline Expands - Timothy SykesARTL Stock Draws Traders As Biotech Pipeline Expands Timothy SykesView source ↗Timothy SykesApr 20, 2026neutral00.6
Top movers in Monday's pre-market session - ChartMillTop movers in Monday's pre-market session ChartMillView source ↗ChartMillApr 20, 2026neutral00.6
Artelo Biosciences, Inc. (ARTL) Stock Price, News, Quote & History - Yahoo! Finance CanadaArtelo Biosciences, Inc. (ARTL) Stock Price, News, Quote & History Yahoo! Finance CanadaView source ↗Yahoo! Finance CanadaApr 8, 2026neutral00.6
Artelo Biosciences, Inc. Announces Private Placement of Common Stock and Warrants, Expected Proceeds of $11 Million | ARTL Stock News - Quiver QuantitativeArtelo Biosciences, Inc. Announces Private Placement of Common Stock and Warrants, Expected Proceeds of $11 Million | ARTL Stock News Quiver QuantitativeView source ↗Quiver QuantitativeMar 27, 2026neutral00.6
Artelo Biosciences, Inc. Announces Private Placement of Common Stock and Warrants, Expected Proceeds of $11 Million | ARTL Stock News - Quiver QuantitativeArtelo Biosciences, Inc. Announces Private Placement of Common Stock and Warrants, Expected Proceeds of $11 Million | ARTL Stock News Quiver QuantitativeView source ↗Quiver QuantitativeMar 27, 2026neutral00.6
Why Did ARTL Stock Skyrocket Over 420% Today? - StocktwitsWhy Did ARTL Stock Skyrocket Over 420% Today? StocktwitsView source ↗StocktwitsMar 25, 2026neutral00.6
Market Movers | Winners: SWMR, ARTL, AIM | Losers: CREG, VHUB, CING - TrefisMarket Movers | Winners: SWMR, ARTL, AIM | Losers: CREG, VHUB, CING TrefisView source ↗TrefisMar 19, 2026neutral00.6
Why Is ARTL Stock Soaring Today? - StocktwitsWhy Is ARTL Stock Soaring Today? StocktwitsView source ↗StocktwitsMar 18, 2026neutral00.6

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.